ArticleDiabetology & metabolic syndrome2026
A U-shaped association between vitamin D and ketone levels in type 2 diabetes: a metabolic state-dependent dual regulation mechanism.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBeyond bone health, vitamin D plays a pivotal role in glucose and lipid homeostasis. Vitamin D deficiency is prevalent in type 2 diabetes (T2DM), potentially exacerbating β-cell dysfunction and dysregulated energy substrate utilization. This study aimed to characterize the complex, potentially non-linear relationship between serum 25-hydroxyvitamin D [25(OH)D], β-hydroxybutyrate (β-OHB), and pancreatic β-cell reserve.
methodsHospitalized T2DM patients were enrolled, excluding those with acute complications or severe organ dysfunction. C-peptide area under the curve (AUC₀–₃h) from a steamed bread meal test was used to assess β-cell reserve. Multiple linear and logistic regressions were employed to evaluate the 25(OH)D-β-OHB association, adjusting for covariates including demographics, glycemic control, lipid profile, comorbidities, and medications (Metformin, SGLT2 inhibitors, insulin). Non-linearity was examined using mean-centered quadratic terms, with robustness verified via Bootstrap resampling and restricted cubic spline (RCS) analysis.
resultsNo independent linear association was observed between 25(OH)D and ln(β-OHB + 0.01) in the overall population (P > 0.05). However, multivariate logistic regression identified 25(OH)D as an independent risk factor for elevated ketones (β-OHB ≥ 0.27 mmol/L; OR = 1.053, P = 0.006), an effect that was more pronounced in the preserved β-cell function group (C-peptide AUC ≥ 8 ng/mL⋅h; OR = 1.062, P = 0.011). Notably, a significant U-shaped relationship between 25(OH)D and β-OHB was confirmed in patients with stable metabolic status (HbA1c ≤ 8.5% and C-peptide AUC ≥ 8 ng/mL⋅h), with an inflection point at 20.5–22.4 ng/mL.
conclusionA robust U-shaped non-linear association exists between serum 25(OH)D and β-OHB, indicating a dual regulatory role of vitamin D in ketone metabolism. Maintaining 25(OH)D at a moderate level (~ 21 ng/mL) may optimize energy substrate utilization, a process significantly modulated by β-cell reserve. These findings underscore the clinical necessity for individualized vitamin D monitoring and precision intervention in T2DM management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.